Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1

Cancer Gene Therapy, 05/15/2012

This study suggests that the combination of LKB1 gene therapy with low–dose cisplatin–based chemotherapy may be a potent therapeutic strategy for lung cancer.

Print Article Summary Cat 2 CME Report